Astec LifeSciences Limited has informed the Exchange regarding Appointment of Mr Arijit Mukherjee as Additional Director (Executive Director & Non-Independent) and Chief Operating Officer of the company w.e.f. April 13, 2026 upto April 12, 2029.
ASTEC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Astec LifeSciences underwent significant leadership changes at its April 13, 2026 board meeting. Long-time Chairman Mr. Nadir Godrej retired and stepped down from the board (turning 75 in August). His son, Mr. Burjis N. Godrej, resigned as Managing Director to focus on Godrej Agrovet Limited (parent company) but will continue as Non-Executive Director. Mr. Vishal Sharma from Godrej Industries Limited (ultimate holding company) was appointed as new Chairman. Mr. Mathew Eipe joined as Independent Director, and Mr. Arijit Mukherjee (existing COO) was elevated to Executive Director & COO for a 3-year term. Post-changes, the board will have 10 directors with 50% independent directors.
The departure of the Godrej family patriarch and restructuring of board roles signals potential shift in governance and strategic direction. Shareholders should monitor for changes in business strategy given Burjis Godrej's move to the parent company and new leadership appointments from the Godrej group.